Antimalarial Activities of ( Z )-2-(Nitroheteroarylmethylene)-3(2 H )-Benzofuranone Derivatives: In Vitro and In Vivo Assessment and β-Hematin Formation Inhibition Activity

Author:

Navidpour Latifeh1ORCID,Chibale Kelly23,Esmaeili Somayeh4,Ghiaee Azadeh4,Hadj-esfandiari Narges1,Irani Mahboubeh4,Ahmadi Koulaei Sheyda5,Yassa Narguess5

Affiliation:

1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2. South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry, University of Cape Town, Rondebosch, South Africa

3. Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa

4. School of Traditional Medicine, Traditional Medicine & Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5. Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Abstract

A series of ( Z )-2-(nitroheteroarylmethylene)-3(2 H )-benzofuranones possessing nitroheteroaryl groups of nitroimidazole, nitrofuran, and nitrothiophene moieties was screened for antiplasmodium activity against a drug-sensitive strain (3D7 strain) and a multidrug-resistant (chloroquine [CQ] and pyrimethamine) strain (K1 strain) of Plasmodium falciparum . 5-Nitroimidazole and 4-nitroimidazole analogs were highly selective and active against resistant parasites, while 5-nitrofuran and 5-nitrothiophene derivatives were more potent against the 3D7 strain than against the K1 strain. Among the synthetic analogues, ( Z )-6-chloro-2-(1-methyl-5-nitroimidazol-2-ylmethylene)-3(2 H )-benzofuranone (compound 5h ) exhibited the highest activity (50% inhibitory concentration [IC 50 ], 0.654 nM) against the K1 strain and ( Z )-7-methoxy-2-(5-nitrothiophen-2-ylmethylene)-3(2 H )-benzofuranone ( 10g ) showed the highest activity (IC 50 , 0.28 μM) against the 3D7 strain in comparison with the activities of CQ (IC 50 s of 3.13 and 206.3 nM against 3D7 and K1 strains, respectively).

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference22 articles.

1. WHO. 2019. The “World malaria report 2019” at a glance. World Health Organization Geneva Switzerland. https://www.who.int/news-room/feature-stories/detail/world-malaria-report-2019.

2. Challenges and opportunities in controlling mosquito-borne infections

3. The current malaria morbidity and mortality in different transmission settings in Western Kenya

4. Comprehensive review on various strategies for antimalarial drug discovery

5. WHO. 2020. Tackling antimalarial drug resistance. Launch of the WHO Report on antimalarial drug efficacy resistance and response: 10 years of surveillance. (2010–2019). World Health Organization Geneva Switzerland. https://www.who.int/docs/default-source/malaria/drug-resistance/who-ucn-gmp-2020-07-eng.pdf?sfvrsn=a2c11533_2&download=true.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3